Rainbow Seed Fund News

May 15th 2018 CellCentric has raised $26 million in private financing to fund clinical testing of its first-in-class oncology drug candidate CCS1477. The funds will be used to test the novel p300/CBP inhibitor in late stage, treatment-resistant prostate cancer (up to Phase IIb). Recent data shared at AACR also highlighted the potential of CCS1477 in […]

read more

Photo Glialign CEO John Sinden London, 2nd May 2018 The UCL Technology Fund (UCLTF), UK Innovation & Science Seed Fund (UKI2S), alongside support from Innovate UK, have invested in UCL spinout company Glialign Ltd, a company that is developing a novel cell therapy for peripheral nerve repair. Hundreds of thousands of people every year are affected […]

read more

Software leader in the field of genomic data and bioinformatics analysis poised for growth 30 April 2018 — Cambridge, UK — Eagle Genomics, leaders in life sciences smart data management and analysis, has appointed Executive Chairman Anthony Finbow to the post of Chief Executive, with founder Abel Ureta-Vidal moving to Chief Product Officer. The change […]

read more

1 2 3 8